Cribbs et al. (2015) showed that the methotrexate treatment of rheumatoid arthritis patients enhances the reduced CTLA4 expression in regulatory T cells and restores their defective suppressor function [13]. Here, CTLA4 is linked to rheumatoid arthritis.